Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

YA Kesäniemi, WF Beltz… - The Journal of Clinical …, 1985 - Am Soc Clin Investig
YA Kesäniemi, WF Beltz, SM Grundy
The Journal of Clinical Investigation, 1985Am Soc Clin Investig
This study was designed to examine the integrated metabolism of apolipoprotein B (apo B)
in very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), and low
density lipoproteins (LDL) in normal subjects, obese patients, and a group of patients with
coronary heart disease (CHD). Turnover rates of 131I-VLDL-B, 131I-IDL-B, 125I-LDL-B, and
[3H] VLDL-triglycerides (TG) were determined by the multicompartmental analysis that used
the model described in the preceding article (Beltz, WF, et al. 1985. J. Clin. Invest. 76: 575 …
This study was designed to examine the integrated metabolism of apolipoprotein B (apo B) in very low density lipoproteins (VLDL), intermediate density lipoproteins (IDL), and low density lipoproteins (LDL) in normal subjects, obese patients, and a group of patients with coronary heart disease (CHD). Turnover rates of 131I-VLDL-B, 131I-IDL-B, 125I-LDL-B, and [3H]VLDL-triglycerides (TG) were determined by the multicompartmental analysis that used the model described in the preceding article (Beltz, W.F., et al. 1985. J. Clin. Invest. 76: 575-585). Compared with five normal subjects, four obese subjects had increased synthesis rates of both VLDL-B and VLDL-TG. Production of LDL-B was inconsistently raised in these same patients. Five patients with CHD had enhanced production of both VLDL-B and LDL-B, but secretion rates of VLDL-TG were not increased. Thus, in patients with obesity and in those with CHD, synthesis rates of VLDL particles may be abnormally high. In the obese patients, the VLDL appeared to be of normal composition, but in patients with CHD, the VLDL were relatively poor in TG. The study also showed that a significant fraction of VLDL-B is removed directly from the circulation and never reaches LDL regardless of the type of patients. The fraction that does reach LDL is one factor that determines LDL concentrations.
The Journal of Clinical Investigation